Company Name
Diamyd

Web Site
www.diamyd.com

Description of Company Mission
The company’s mission is to develop and commercialize novel therapeutics for the treatment of pain and diseases of the peripheral nervous system that cause nerve damage.

Industry
Therapeutics

Stage of Commercialization
Exit

Market Size
$3B

PLSG Funding to Date
$100,000

Other Management Name
Michael Wolfe

Number of Employees
4

Location
Pittsburgh, PA